Five new teams selected to take on cancer’s toughest challenges
Today we’re excited to announce the five new global teams that have been selected to each receive up to $25m in Cancer Grand Challenges funding over five years to take on four of cancer’s toughest challenges. In March 2023, we announced…
In November 2022, Cancer Grand Challenges held its first in-person Future Leaders Conference in Barcelona, providing an opportunity for early-career researchers worldwide to connect, network and spark new scientific…
Cancer Grand Challenges research covers a broad spectrum of areas and disciplines, with teams generating novel insights at each stage of the research pipeline.
Here, Gemma Balmer-Kemp, head of research at Cancer Grand…
Cancer Grand Challenges awarded grants to four teams –CANCAN, PROMINENT, eDyNAmiC and NexTGen – in its third round of funding in 2022. Charles Swanton, a member of the Cancer Grand Challenges Scientific Committee,…
Lorenzo de la Rica, Research Programme Manager at Cancer Grand Challenges, provides his insights on the importance of the latest paper from the Cancer Grand Challenges eDyNAmiC team, tackling the extrachromosomal DNA…
When it comes to cancer research, we regularly hear good news about the number of people benefiting from advances in treatment. But there is one bad news story about the condition that gets little attention. For three…
Today we announce nine new Cancer Grand Challenges, for which Expressions of Interest are now open. These are the obstacles that continue to impede progress against cancer and that no one scientist, institution or…
We are pleased to welcome five new members to the Cancer Grand Challenges Scientific Committee: Professor Michael Hall (University of Basel), Professor Sherene Loi (Peter MacCallum Cancer Center), Professor KJ Patel (…
Lorenzo de la Rica (@LdelaRica) is Research Portfolio Manager at Cancer Grand Challenges
In 2022, we have seen our Cancer Grand Challenges (CGC) community grow, with four new teams receiving a total of $100m funding.…
In 2017, the IMAXT team was awarded £20 million by Cancer Grand Challenges, funded by Cancer Research UK.
Through the Cancer Grand Challenges initiative, a global team of experts from fields as diverse as medicine,…